6-{[(3-Bromo-phenyl)-prop-2-ynyl-amino]-methyl}-2-methyl-3H-quinazolin-4-one

ID: ALA172085

PubChem CID: 135513984

Max Phase: Preclinical

Molecular Formula: C19H16BrN3O

Molecular Weight: 382.26

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  C#CCN(Cc1ccc2nc(C)nc(O)c2c1)c1cccc(Br)c1

Standard InChI:  InChI=1S/C19H16BrN3O/c1-3-9-23(16-6-4-5-15(20)11-16)12-14-7-8-18-17(10-14)19(24)22-13(2)21-18/h1,4-8,10-11H,9,12H2,2H3,(H,21,22,24)

Standard InChI Key:  ZDBCVGCWPPMHDD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.6125   -2.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250   -3.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1083   -3.1917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6125   -4.4292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250   -4.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1083   -4.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1875   -3.1917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7792   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0125   -3.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1687   -1.2484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0375   -2.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4417   -3.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6125   -1.9542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4667   -2.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7500   -3.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0375   -4.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2750   -3.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3792   -2.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7542   -4.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7042   -4.5542    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -0.8250   -4.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4042   -2.4500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2292   -2.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6625   -3.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  2  0
  4  6  2  0
  5  2  2  0
  6  3  1  0
  7 14  1  0
  8 18  1  0
  9  7  1  0
 10  8  3  0
 11  2  1  0
 12  9  2  0
 13  1  1  0
 14 15  1  0
 15 11  2  0
 16  5  1  0
 17 12  1  0
 18  7  1  0
 19 15  1  0
 20 17  1  0
 21  6  1  0
 22  9  1  0
 23 22  2  0
 24 23  1  0
  5  4  1  0
 16 19  2  0
 17 24  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA172085

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 382.26

Molecular Weight (Monoisotopic): 381.0477

AlogP: 4.05

#Rotatable Bonds: 4

Polar Surface Area: 49.25

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 12.82

CX Basic pKa: 1.82

CX LogP: 5.23

CX LogD: 5.23

Aromatic Rings: 3

Heavy Atoms: 24

QED Weighted: 0.69

Np Likeness Score: -1.62

References

1. Jones TR, Varney MD, Webber SE, Lewis KK, Marzoni GP, Palmer CL, Kathardekar V, Welsh KM, Webber S, Matthews DA, Appelt K, Smith WW, Janson CA, Villafranca JE, Bacquet RJ, Howland EF, Booth CL, Herrmann SM, Ward RW, White J, Moomaw EW, Bartlett CA, Morse CA..  (1996)  Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.,  39  (4): [PMID:8632414] [10.1021/jm9502652]

Source

Source(1):

• Scientific Literature